Drug intelligence / Profile preview

KangJunXiaoYan Capsule

Development stage: Unknown
Lead developer: Qionglai Tianyin Pharmaceutical
Administration: Oral

Overview

KangJunXiaoYan Capsule is a Traditional Chinese Medicine (TCM) product developed by Shanxi Buchang Pharmaceutical and manufactured by its subsidiary, Qionglai Tianyin Pharmaceutical. Formulated as a hard capsule for oral administration, it contains a combination of seven botanical extracts: Lonicera japonica (honeysuckle), Stemona sessilifolia, Rheum palmatum (rhubarb), Isatis indigotica (isatis leaf), Anemarrhena asphodeloides, Scutellaria baicalensis (baical skullcap), and Desmodium styracifolium. The drug is indicated for clearing heat and detoxifying, specifically for the treatment of wind-heat colds, sore throats (pharyngitis/tonsillitis), and inflammatory conditions of the respiratory tract. It is currently approved and marketed in China.

Brand names: KangJunXiaoYan Capsule
Other names: Kangjun Xiaoyan Jiaonang抗菌消炎胶囊

Beyond the preview

Go deeper on KangJunXiaoYan Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KangJunXiaoYan Capsule.

Explore the full profile